155 related articles for article (PubMed ID: 20975378)
1. Characteristics of thoracic malignancies that occur after solid-organ transplantation.
Génébès C; Brouchet L; Kamar N; Lepage B; Prévot G; Rostaing L; Didier A; Mazières J
J Thorac Oncol; 2010 Nov; 5(11):1789-95. PubMed ID: 20975378
[TBL] [Abstract][Full Text] [Related]
2. [Lung cancer surgery in solid organ transplanted patients].
Arame A; Rivera C; Borik W; Mangiameli G; Abdennahder M; Pricopi C; Bagan P; Badia A; Le Pimpec Barthes F; Riquet M
Rev Pneumol Clin; 2014 Dec; 70(6):315-21. PubMed ID: 25131366
[TBL] [Abstract][Full Text] [Related]
3. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract][Full Text] [Related]
4. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
5. Multiple independent primary cancers do not adversely affect survival of the lung cancer patient.
Aguiló R; Macià F; Porta M; Casamitjana M; Minguella J; Novoa AM
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1075-80. PubMed ID: 18824369
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer in patients with idiopathic pulmonary fibrosis: clinical characteristics and impact on survival.
Lee T; Park JY; Lee HY; Cho YJ; Yoon HI; Lee JH; Jheon S; Lee CT; Park JS
Respir Med; 2014 Oct; 108(10):1549-55. PubMed ID: 25175479
[TBL] [Abstract][Full Text] [Related]
7. Cancer of the head and neck region in solid organ transplant recipients.
Rabinovics N; Mizrachi A; Hadar T; Ad-El D; Feinmesser R; Guttman D; Shpitzer T; Bachar G
Head Neck; 2014 Feb; 36(2):181-6. PubMed ID: 23554129
[TBL] [Abstract][Full Text] [Related]
8. [A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
Kishimoto T
Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):304-9. PubMed ID: 12795187
[TBL] [Abstract][Full Text] [Related]
9. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
[TBL] [Abstract][Full Text] [Related]
11. Early mortality in lung cancer: French prospective multicentre observational study.
Grivaux M; Debieuvre D; Herman D; Lemonnier C; Marcos JM; Crequit J; Vuillermoz-Blas S; Barre P; Saillour M; Martin F
BMC Pulm Med; 2016 Apr; 16():45. PubMed ID: 27039176
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
[TBL] [Abstract][Full Text] [Related]
13. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
14. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
15. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
Svensson G; Ewers SB; Ohlsson O; Olsson H
Clin Respir J; 2013 Jan; 7(1):91-100. PubMed ID: 22380488
[TBL] [Abstract][Full Text] [Related]
17. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.
Oshiro Y; Mizumoto M; Okumura T; Hashimoto T; Fukumitsu N; Ohkawa A; Kanemoto A; Hashii H; Ohno T; Sakae T; Tsuboi K; Sakurai H
J Thorac Oncol; 2012 Feb; 7(2):370-5. PubMed ID: 22157368
[TBL] [Abstract][Full Text] [Related]
18. Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients.
Sigel K; Veluswamy R; Krauskopf K; Mehrotra A; Mhango G; Sigel C; Wisnivesky J
Transplantation; 2015 Oct; 99(10):2181-9. PubMed ID: 25839704
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.
Yoshino I; Yoshida S; Miyaoka E; Asamura H; Nomori H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
J Thorac Oncol; 2012 May; 7(5):850-5. PubMed ID: 22481238
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
